Skip to main content
SpringerLink
Log in

Joint Preservation after Extensive Curettage of Knee Giant Cell Tumors

  • Symposium: Selected Papers Presented at the 2008 Meeting of the Musculoskeletal Tumor Society
  • Published:
Clinical Orthopaedics and Related Research®

Abstract

Curettage is the most attractive procedure for surgically treating a giant cell tumor because it preserves joint function. However, since many giant cell tumors compromise subchondral bone this technique can jeopardize the articular surface with subsequent fractures or collapse. We asked whether intralesional curettage of a giant cell tumor close to the knee that combined morselized bone and cortical structural allograft would preserve joint function. We retrospectively reviewed 22 patients treated with that approach. The minimum followup was 2 years (average, 48 months; range, 24–80 months). The distal femur was involved in 12 patients and proximal tibia in 10. Complications and failures were recorded and functional results evaluated with Musculoskeletal Tumor Society score. We determined survivorship using the Kaplan-Meier technique using removal of the implant as the endpoint. The survival was 85% and the average functional score 28 points. Three of the 22 patients had a local tumor recurrence and one had a partial subchondral collapse not requiring further treatment. Among the remaining patients, none had fracture, infection, or knee instability. The combination of fragmented and cortical allograft allows reconstructing the bone defect and ligaments created after extensive curettage of a knee giant cell tumor obtaining normal joint function and a high survival rate with minimal complications in a high percentage of the patients.

Level of Evidence: Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1A–C
Fig. 2A–D
Fig. 3A–C
Fig. 4A–C
Fig. 5
Fig. 6A–B

Similar content being viewed by others

References

  1. Arbeitsgemeinschaft Knochentumoren, Becker WT, Dohle J, Bernd L, Braun A, Cserhati M, Enderle A, Hovy L, Matejovsky Z, Szendroi M, Trieb K, Tunn PU. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy. J Bone Joint Surg Am. 2008;90:1060–1067.

    Article  Google Scholar 

  2. Ayerza MA, Aponte-Tinao LA, Muscolo DL, Abalo ED. Morsellized and structural cortical allograft reconstruction after intralesional curettage of a distal femoral giant-cell tumor. Orthopedics. 2006;29:679–682.

    PubMed  Google Scholar 

  3. Balke M, Schremper L, Gebert C, Ahrens H, Streitbuerger A, Koehler G, Hardes J, Gosheger G. Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol. 2008;134:969–978.

    Article  PubMed  CAS  Google Scholar 

  4. Blackley HR, Wunder JS, Davis AM, White LM, Kandel R, Bell RS. Treatment of giant-cell tumors of long bones with curettage and bone-grafting. J Bone Joint Surg Am. 1999;81:811–820.

    Article  PubMed  CAS  Google Scholar 

  5. Buecker PJ, Gebhardt MC. Are fibula strut allografts a reliable alternative for periarticular reconstruction after curettage for bone tumors? Clin Orthop Relat Res. 2007;461:170–174.

    PubMed  Google Scholar 

  6. Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am. 1987;69:106–114.

    PubMed  CAS  Google Scholar 

  7. Eckardt JJ, Grogan TJ. Giant cell tumor of bone. Clin Orthop Relat Res. 1986;204:45–58.

    PubMed  Google Scholar 

  8. Enneking WF, Dunham W, Gebhardt MC, Malawer M, Prichard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993;286:241–246.

    PubMed  Google Scholar 

  9. Gitelis S, Mallin BA, Piasecki P, Turner F. Intralesional excision compared with en bloc resection for giant-cell tumor of bone. J Bone Joint Surg Am. 1993;75:1648–1655.

    PubMed  CAS  Google Scholar 

  10. Glasser D, Langlais F. The ISOLS radiological implant evaluation system. In: Langlais F, Tomeno B, eds. Limb Salvage: Major Reconstructions in Oncologic and Nontumoral Conditions. Heidelberg, Germany: Springer-Verlag; 1991.

    Google Scholar 

  11. Kivioja AH, Blomqvist C, Hietaniemi K, Trovik C, Walloe A, Bauer HC, Jorgensen PH, Bergh P, Follerås G. Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years. Acta Orthop. 2008;79:86–93.

    Article  PubMed  Google Scholar 

  12. Li JM, Yang ZP, Li ZF, Li X, Carter SR. Knee reconstruction with preservation of the meniscus in tibial giant cell tumor. Clin Orthop Relat Res. 2008;466:3101–3107.

    Article  PubMed  Google Scholar 

  13. Malawer MM, Bickels J, Meller I, Buch RG, Henshaw RM, Kollender Y. Cryosurgery in the treatment of giant cell tumor: a long-term followup study. Clin Orthop Relat Res. 1999;359:176–188.

    Article  PubMed  Google Scholar 

  14. McDonald DJ, Sim FH, McLeod RA, Dahlin DC. Giant-cell tumor of bone. J Bone Joint Surg Am. 1986;68:235–242.

    PubMed  CAS  Google Scholar 

  15. Muscolo DL, Ayerza MA, Aponte-Tinao LA. Massive allograft use in orthopedic oncology. Orthop Clin North Am. 2006;37:65–74.

    Article  PubMed  Google Scholar 

  16. Muscolo DL, Ayerza MA, Calabrese ME, Gruenberg M. The use of a bone allograft for reconstruction after resection of giant-cell tumor close to the knee. J Bone Joint Surg Am. 1993;75:1656–1662.

    PubMed  CAS  Google Scholar 

  17. Persson BM, Ekelund L, Lövdahl R, Gunterberg B. Favourable results of acrylic cementation for giant cell tumors. Acta Orthop Scand. 1984;55:209–214.

    Article  PubMed  CAS  Google Scholar 

  18. Prosser GH, Baloch KG, Tillman RM, Carter SR, Grimer RJ. Does curettage without adjuvant therapy provide low recurrence rates in giant-cell tumors of bone? Clin Orthop Relat Res. 2005;435:211–218.

    Article  PubMed  Google Scholar 

  19. Schindler OS, Cannon SR, Briggs TW, Blunn GW. Use of a novel bone graft substitute in peri-articular bone tumours of the knee. Knee. 2007;14:458–464.

    Article  PubMed  Google Scholar 

  20. Sung HW, Kuo DP, Shu WP, Chai YB, Liu CC, Li SM. Giant cell tumor of bone: analysis of two hundred and eight cases in Chinese patients. J Bone Joint Surg Am. 1982;64:755–761.

    PubMed  CAS  Google Scholar 

  21. Turcotte RE, Wunder JS, Isler MH, Bell RS, Schachar N, Masri BA, Moreau G, Davis AM, Canadian Sarcoma Group. Giant cell tumor of long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res. 2002;397:248–258.

    Article  PubMed  Google Scholar 

  22. Ward WG Sr, Li G 3rd. Customized treatment algorithm for giant cell tumor of bone: report of a series. Clin Orthop Relat Res. 2002;397:259–270.

    Article  PubMed  Google Scholar 

  23. Zhen W, Yaotian H, Songjian L, Ge L, Qingliang W. Giant-cell tumour of bone: the long-term results of treatment by curettage and bone graft. J Bone Joint Surg Br. 2004;86:212–216.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Orthopedics “Carlos E. Ottolenghi,” Italian Hospital of Buenos Aires, Potosí 4247 (1199), Buenos Aires, Argentina

    Miguel A. Ayerza MD, Luis A. Aponte-Tinao MD, German L. Farfalli MD, Carlos A. Lores Restrepo MD & D. Luis Muscolo MD

Authors
  1. Miguel A. Ayerza MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luis A. Aponte-Tinao MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. German L. Farfalli MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carlos A. Lores Restrepo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Luis Muscolo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Miguel A. Ayerza MD.

Additional information

Each author certifies that he or she has no commercial associations (eg, consultancies, stock ownership, equity interest, patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article.

Each author certifies that his institution has approved the reporting of this case report and that all investigations were conducted in conformity with ethical principles of research.

About this article

Cite this article

Ayerza, M.A., Aponte-Tinao, L.A., Farfalli, G.L. et al. Joint Preservation after Extensive Curettage of Knee Giant Cell Tumors. Clin Orthop Relat Res 467, 2845–2851 (2009). https://doi.org/10.1007/s11999-009-0913-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11999-009-0913-8

Keywords

Search

Navigation